Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure

Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the American Thoracic Society 2022-08, Vol.19 (8), p.1275-1284
Hauptverfasser: Raidt, Johanna, Krenz, Henrike, Tebbe, Johannes, Große-Onnebrink, Jörg, Olbrich, Heike, Loges, Niki Tomas, Biebach, Luisa, Schmalstieg, Christian, Keßler, Christina, Wallmeier, Julia, Dworniczak, Bernd, Pennekamp, Petra, Dugas, Martin, Werner, Claudius, Omran, Heymut
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1284
container_issue 8
container_start_page 1275
container_title Annals of the American Thoracic Society
container_volume 19
creator Raidt, Johanna
Krenz, Henrike
Tebbe, Johannes
Große-Onnebrink, Jörg
Olbrich, Heike
Loges, Niki Tomas
Biebach, Luisa
Schmalstieg, Christian
Keßler, Christina
Wallmeier, Julia
Dworniczak, Bernd
Pennekamp, Petra
Dugas, Martin
Werner, Claudius
Omran, Heymut
description Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive. To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes. This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated. The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure. Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 10
doi_str_mv 10.1513/AnnalsATS.202106-728OC
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2633848592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2698703842</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</originalsourceid><addsrcrecordid>eNpdkUtPwzAQhC0Eggr4C5UlLlxS_Igd-1i1vKTSItGeI9dxwCWJwXYE_HvcFjiwl93DNyPNDgBDjEaYYXo17jrVhPHyaUQQwYhnBRGLyQEYEEpYxjnBh7tbZlxSegLOQ9igNIJhUchjcEJZEjImByDObGujitZ1AboazlVQDZzb6K2Gi09bGfhgVOi9aU0XYe08nFr13Llgd_yjt63yX3BiG7vd06_wajsTrIIfNr7AufNtMlw10asQfa9jsjoDR3UKYM5_9ilY3VwvJ3fZbHF7PxnPMk2pjJnmkqFaUW6ETmlUjnKjKdFrkVd1QbkupOYcV1rInApmMNNMiypfo7zCSit6Ci73vm_evfcmxLK1QZumUZ1xfSgJp1TkgkmS0It_6Mb1fvvmRElRoARuKb6ntHcheFOXb_v8JUbltpryr5pyX025qyYJhz_2_bo11Z_stwj6DcmojTM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2698703842</pqid></control><display><type>article</type><title>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</title><source>American Thoracic Society (ATS) Journals Online</source><source>Alma/SFX Local Collection</source><creator>Raidt, Johanna ; Krenz, Henrike ; Tebbe, Johannes ; Große-Onnebrink, Jörg ; Olbrich, Heike ; Loges, Niki Tomas ; Biebach, Luisa ; Schmalstieg, Christian ; Keßler, Christina ; Wallmeier, Julia ; Dworniczak, Bernd ; Pennekamp, Petra ; Dugas, Martin ; Werner, Claudius ; Omran, Heymut</creator><creatorcontrib>Raidt, Johanna ; Krenz, Henrike ; Tebbe, Johannes ; Große-Onnebrink, Jörg ; Olbrich, Heike ; Loges, Niki Tomas ; Biebach, Luisa ; Schmalstieg, Christian ; Keßler, Christina ; Wallmeier, Julia ; Dworniczak, Bernd ; Pennekamp, Petra ; Dugas, Martin ; Werner, Claudius ; Omran, Heymut</creatorcontrib><description>Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive. To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes. This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated. The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure. Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 107.8 nl/min might promote diagnosing PCD with normal ultrastructure.</description><identifier>ISSN: 2329-6933</identifier><identifier>EISSN: 2325-6621</identifier><identifier>DOI: 10.1513/AnnalsATS.202106-728OC</identifier><identifier>PMID: 35202559</identifier><language>eng</language><publisher>United States: American Thoracic Society</publisher><subject>Dyskinesia ; Genotype &amp; phenotype ; Medical diagnosis ; Medical research ; Nitric oxide</subject><ispartof>Annals of the American Thoracic Society, 2022-08, Vol.19 (8), p.1275-1284</ispartof><rights>Copyright American Thoracic Society Aug 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</citedby><cites>FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35202559$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raidt, Johanna</creatorcontrib><creatorcontrib>Krenz, Henrike</creatorcontrib><creatorcontrib>Tebbe, Johannes</creatorcontrib><creatorcontrib>Große-Onnebrink, Jörg</creatorcontrib><creatorcontrib>Olbrich, Heike</creatorcontrib><creatorcontrib>Loges, Niki Tomas</creatorcontrib><creatorcontrib>Biebach, Luisa</creatorcontrib><creatorcontrib>Schmalstieg, Christian</creatorcontrib><creatorcontrib>Keßler, Christina</creatorcontrib><creatorcontrib>Wallmeier, Julia</creatorcontrib><creatorcontrib>Dworniczak, Bernd</creatorcontrib><creatorcontrib>Pennekamp, Petra</creatorcontrib><creatorcontrib>Dugas, Martin</creatorcontrib><creatorcontrib>Werner, Claudius</creatorcontrib><creatorcontrib>Omran, Heymut</creatorcontrib><title>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</title><title>Annals of the American Thoracic Society</title><addtitle>Ann Am Thorac Soc</addtitle><description>Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive. To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes. This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated. The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure. Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 107.8 nl/min might promote diagnosing PCD with normal ultrastructure.</description><subject>Dyskinesia</subject><subject>Genotype &amp; phenotype</subject><subject>Medical diagnosis</subject><subject>Medical research</subject><subject>Nitric oxide</subject><issn>2329-6933</issn><issn>2325-6621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkUtPwzAQhC0Eggr4C5UlLlxS_Igd-1i1vKTSItGeI9dxwCWJwXYE_HvcFjiwl93DNyPNDgBDjEaYYXo17jrVhPHyaUQQwYhnBRGLyQEYEEpYxjnBh7tbZlxSegLOQ9igNIJhUchjcEJZEjImByDObGujitZ1AboazlVQDZzb6K2Gi09bGfhgVOi9aU0XYe08nFr13Llgd_yjt63yX3BiG7vd06_wajsTrIIfNr7AufNtMlw10asQfa9jsjoDR3UKYM5_9ilY3VwvJ3fZbHF7PxnPMk2pjJnmkqFaUW6ETmlUjnKjKdFrkVd1QbkupOYcV1rInApmMNNMiypfo7zCSit6Ci73vm_evfcmxLK1QZumUZ1xfSgJp1TkgkmS0It_6Mb1fvvmRElRoARuKb6ntHcheFOXb_v8JUbltpryr5pyX025qyYJhz_2_bo11Z_stwj6DcmojTM</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Raidt, Johanna</creator><creator>Krenz, Henrike</creator><creator>Tebbe, Johannes</creator><creator>Große-Onnebrink, Jörg</creator><creator>Olbrich, Heike</creator><creator>Loges, Niki Tomas</creator><creator>Biebach, Luisa</creator><creator>Schmalstieg, Christian</creator><creator>Keßler, Christina</creator><creator>Wallmeier, Julia</creator><creator>Dworniczak, Bernd</creator><creator>Pennekamp, Petra</creator><creator>Dugas, Martin</creator><creator>Werner, Claudius</creator><creator>Omran, Heymut</creator><general>American Thoracic Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20220801</creationdate><title>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</title><author>Raidt, Johanna ; Krenz, Henrike ; Tebbe, Johannes ; Große-Onnebrink, Jörg ; Olbrich, Heike ; Loges, Niki Tomas ; Biebach, Luisa ; Schmalstieg, Christian ; Keßler, Christina ; Wallmeier, Julia ; Dworniczak, Bernd ; Pennekamp, Petra ; Dugas, Martin ; Werner, Claudius ; Omran, Heymut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-c6950fa36e8c232a404ec32cb84df736c79c661dc894385e15c5c8d4b04d1aca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Dyskinesia</topic><topic>Genotype &amp; phenotype</topic><topic>Medical diagnosis</topic><topic>Medical research</topic><topic>Nitric oxide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raidt, Johanna</creatorcontrib><creatorcontrib>Krenz, Henrike</creatorcontrib><creatorcontrib>Tebbe, Johannes</creatorcontrib><creatorcontrib>Große-Onnebrink, Jörg</creatorcontrib><creatorcontrib>Olbrich, Heike</creatorcontrib><creatorcontrib>Loges, Niki Tomas</creatorcontrib><creatorcontrib>Biebach, Luisa</creatorcontrib><creatorcontrib>Schmalstieg, Christian</creatorcontrib><creatorcontrib>Keßler, Christina</creatorcontrib><creatorcontrib>Wallmeier, Julia</creatorcontrib><creatorcontrib>Dworniczak, Bernd</creatorcontrib><creatorcontrib>Pennekamp, Petra</creatorcontrib><creatorcontrib>Dugas, Martin</creatorcontrib><creatorcontrib>Werner, Claudius</creatorcontrib><creatorcontrib>Omran, Heymut</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the American Thoracic Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raidt, Johanna</au><au>Krenz, Henrike</au><au>Tebbe, Johannes</au><au>Große-Onnebrink, Jörg</au><au>Olbrich, Heike</au><au>Loges, Niki Tomas</au><au>Biebach, Luisa</au><au>Schmalstieg, Christian</au><au>Keßler, Christina</au><au>Wallmeier, Julia</au><au>Dworniczak, Bernd</au><au>Pennekamp, Petra</au><au>Dugas, Martin</au><au>Werner, Claudius</au><au>Omran, Heymut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure</atitle><jtitle>Annals of the American Thoracic Society</jtitle><addtitle>Ann Am Thorac Soc</addtitle><date>2022-08-01</date><risdate>2022</risdate><volume>19</volume><issue>8</issue><spage>1275</spage><epage>1284</epage><pages>1275-1284</pages><issn>2329-6933</issn><eissn>2325-6621</eissn><abstract>Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend measurement of nasal nitric oxide (nNO) for PCD diagnosis. Several studies demonstrated low nNO-production rates in PCD individuals but underlying causes remain elusive. To determine nNO-production rates in a well-characterized PCD cohort including subgroup analyses with regard to ultrastructural and ciliary beating phenotypes. This study included 301 individuals assessed according to ERS guidelines. Diagnostic cutoffs for nNO-production rates for this study cohort and subgroups with normal and abnormal ultrastructure were determined. Diagnostic accuracy was also tested for the widely used 77 nl/min-cutoff in this study cohort. The relationship between nNO-production rates and ciliary beat frequencies (CBFs) was evaluated. The study cohort comprised 180 individuals with definite PCD diagnosis including 160 individuals with genetic diagnosis, 16 individuals with probable PCD diagnosis and 105 disease controls. The 77 nl/min nNO-cutoff showed a test sensitivity of 0.92 and specificity of 0.86. Test sensitivity was lower (0.85) in the subgroup of 47 PCD individuals with normal ultrastructure compared to 133 PCD individuals with abnormal ultrastructure (0.95). The optimal diagnostic cutoff for the nNO-production rate for the whole study cohort was 69.8 nl/min (sensitivity 0.92, specificity 0.89), however it was 107.8 nl/min (sensitivity 0.89, specificity 0.78) for the subgroup of PCD with normal ultrastructure. PCD individuals with normal ultrastructure compared to abnormal ultrastructure showed higher ciliary motility. Consistently, PCD individuals with higher CBFs showed higher nNO-production rates. In addition, laterality defects occurred less frequently in PCD with normal ultrastructure. Measurements of nNO below the widely used 77 nL/min cutoff are less sensitive in detecting PCD individuals with normal ultrastructure. Our findings indicate, that higher nNO-production in this subgroup with a higher cutoff for the nNO-production rate (107.8 nl/min) and higher residual ciliary motility are dependent on the underlying molecular PCD defect. Higher nNO-production rates, higher residual CBFs and the lower prevalence of laterality defects hamper diagnosis of PCD with normal ultrastructure. Adjusting the cutoff of nNO-production rate to 107.8 nl/min might promote diagnosing PCD with normal ultrastructure.</abstract><cop>United States</cop><pub>American Thoracic Society</pub><pmid>35202559</pmid><doi>10.1513/AnnalsATS.202106-728OC</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2329-6933
ispartof Annals of the American Thoracic Society, 2022-08, Vol.19 (8), p.1275-1284
issn 2329-6933
2325-6621
language eng
recordid cdi_proquest_miscellaneous_2633848592
source American Thoracic Society (ATS) Journals Online; Alma/SFX Local Collection
subjects Dyskinesia
Genotype & phenotype
Medical diagnosis
Medical research
Nitric oxide
title Limitations of Nasal Nitric Oxide Measurement for Diagnosis of Primary Ciliary Dyskinesia with Normal Ultrastructure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T04%3A34%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Limitations%20of%20Nasal%20Nitric%20Oxide%20Measurement%20for%20Diagnosis%20of%20Primary%20Ciliary%20Dyskinesia%20with%20Normal%20Ultrastructure&rft.jtitle=Annals%20of%20the%20American%20Thoracic%20Society&rft.au=Raidt,%20Johanna&rft.date=2022-08-01&rft.volume=19&rft.issue=8&rft.spage=1275&rft.epage=1284&rft.pages=1275-1284&rft.issn=2329-6933&rft.eissn=2325-6621&rft_id=info:doi/10.1513/AnnalsATS.202106-728OC&rft_dat=%3Cproquest_cross%3E2698703842%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2698703842&rft_id=info:pmid/35202559&rfr_iscdi=true